HOME >> MEDICINE >> NEWS
Study examined switching rates between Allegra® (fexofenadine HCl) and Claritin®

CHICAGO, Il., November 13, 1999 - A higher percentage of seasonal allergic rhinitis (SAR) patients switched to Allegra® (fexofenadine HCl) from Claritin® (loratadine) than vice versa in the spring and fall of 1997 and 1998, according to the results of a study of more than 33,000 patients presented at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI).

The findings are based on "Prescribing Patterns of Non-sedating Antihistamines and Daily Dose Differences in a Managed Care Population," a study that evaluated the continuity of allergy treatment by drug and by allergy season (spring, fall 1997- 1998). The retrospective study analyzed data from physicians' claims from 12 United Healthcare health plans.

During the study period, an average of 12.6 percent of patients taking Claritin switched to Allegra versus 10.0 percent of patients who switched from Allegra to Claritin. "Usage data about newer therapies is important for managed care organizations to analyze so they can understand physician and patient preferences," said Lewis Roht, M.D., Director of Drug Surveillance and Epidemiology at Hoechst Marion Roussel.

Other Studies
Other data presented at the ACAAI meeting by Hoechst Marion Roussel included:

  • A four-week, multicenter, double-blind, randomized, placebo-controlled study which showed that Allegra at doses of 20, 60, 120, and 240 mg reduced pruritus and number of wheals scores over a four-week period for the treatment of chronic idiopathic urticaria (CIU), also known as hives. The study demonstrated that all doses of Allegra greatly reduced the symptoms compared to placebo (P0.0115). Additionally, patients who received Allegra experienced significantly less interference with sleep and daily activities than patients who received placebo (P0.0014). Twice-daily doses of 60 mg or greater were most effective. Adverse events occurred with similar incidence in all treatment groups, with
    '"/>


Contact: Suzanne Wiele
816-966-3475
Porter Novelli
12-Nov-1999


Page: 1 2

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
(Date:5/25/2015)... 25, 2015 Thousands of DePuy ... forward in the federal multidistrict litigation now underway ... According to a Motion filed on May 20th, ... the Case Management Order pertaining to the Limited ... the Motion seeks the adoption of a new ...
(Date:5/25/2015)... May 25, 2015 Burke Rehabilitation Hospital ... PBDW Architects in New York City, to speak at Burke ... the hospital’s ongoing Legacy Lobby Lecture series, will take place ... White is the great grandson of Stanford White of McKim, ... design of Burke’s campus 100 years ago. , “We are ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 For people ... and Chinese Enterokinase Industry, 2009-2019 Market Research Report would ... is an exhaustive study on the present market scenario ... insight into the growing Chinese market of this industry. ... the overall status of the manufacturers in this industry. ...
(Date:5/24/2015)... ProPin is a set of self-animating ... Utilize ProPin to pin point locations on a map, to ... , ProPin allows users to choose from 30 simplistic presets with ... on-screen controls, video editors can easily manipulate ProPin presets as a ... with absolute ease. , Using ProPin is easy, simply drag a ...
(Date:5/23/2015)... On Saturday, May 23, 2015, over 100 volunteers ... Florida City exactly five years to the day after the ... A large fire tore through the Branches United Methodist Church ... the middle of the night as neighbors, staff and Branches' ... even though it is suspected that the fire began accidentally. ...
Breaking Medicine News(10 mins):Health News:Federal DePuy Pinnacle Hip Lawsuits Move Forward, as Plaintiffs Seek to Modify Order Pertaining to Health Authorizations 2Health News:Federal DePuy Pinnacle Hip Lawsuits Move Forward, as Plaintiffs Seek to Modify Order Pertaining to Health Authorizations 3Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 2Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Five Years After Fire, Branches Rebuilds Playground 2
(Date:5/22/2015)... May 22, 2015  China Nepstar Chain Drugstore Ltd. (NYSE: ... retail drugstore chain in China ... announced the resignation of Mr. Fuxiang Zhang ... effective immediately. Ms. Rebecca Yingnan Zhang has ... board of directors, effective immediately. Meanwhile, Ms. Zhang resigned ...
(Date:5/21/2015)... 21, 2015 Research ... the addition of the "Arthroscopy Devices ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The purpose of ... the world market for Arthroscopy Devices. The ... impacting the market for these products. , ...
(Date:5/21/2015)... NEW YORK , 21. Mai ... (NASDAQ: DPRX ), ein Unternehmen ... sich auf die Entwicklung und Vermarktung ... Forschungszusammenarbeit konzentriert, kündigte heute eine wissenschaftliche ... der Phase-III-Zulassungsstudie des Unternehmens vorstellt, OneStep-1 ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
Cached News: